Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma.

Duplisea JJ, Petros FG, Li R, Fellman B, Guo CC, Czerniak BA, Siefker-Radtke AO, Araujo JC, Dinney CPN, Matin SF.

Urol Oncol. 2019 Feb 15. pii: S1078-1439(19)30047-X. doi: 10.1016/j.urolonc.2019.01.026. [Epub ahead of print]

PMID:
30777393
2.

Universal fluctuations in growth dynamics of economic systems.

Frey NC, Matin S, Stanley HE, Salinger MA.

Sci Rep. 2019 Jan 24;9(1):713. doi: 10.1038/s41598-018-38088-z.

3.

Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma.

Petros FG, Qiao W, Singla N, Clinton TN, Robyak H, Raman JD, Margulis V, Matin SF.

Urol Oncol. 2018 Dec 22. pii: S1078-1439(18)30494-0. doi: 10.1016/j.urolonc.2018.12.002. [Epub ahead of print]

PMID:
30584035
4.

Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging.

Yu KJ, Keskin SK, Meissner MA, Petros FG, Wang X, Borregales LD, Gu C, Tamboli P, Matin SF, Wood CG, Karam JA.

Cancer. 2018 Oct 15;124(20):4023-4031. doi: 10.1002/cncr.31661. Epub 2018 Oct 1.

PMID:
30276798
5.

Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.

Jonasch E, McCutcheon IE, Gombos DS, Ahrar K, Perrier ND, Liu D, Robichaux CC, Villarreal MF, Weldon JA, Woodson AH, Pilie PG, Fuller GN, Waguespack SG, Matin SF.

Lancet Oncol. 2018 Oct;19(10):1351-1359. doi: 10.1016/S1470-2045(18)30487-X. Epub 2018 Sep 17.

PMID:
30236511
6.

The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy.

Peyton CC, Abel EJ, Chipollini J, Boulware DC, Azizi M, Karam JA, Margulis V, Master VA, Matin SF, Raman JD, Sexton WJ, Wood CG, Spiess PE.

Eur Urol Focus. 2018 Sep 8. pii: S2405-4569(18)30242-6. doi: 10.1016/j.euf.2018.08.023. [Epub ahead of print]

PMID:
30206003
7.

Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence.

Zhang J, Ye Y, Chang DW, Lin SH, Huang M, Tannir NM, Matin S, Karam JA, Wood CG, Chen ZN, Wu X.

Am J Pathol. 2018 Nov;188(11):2487-2496. doi: 10.1016/j.ajpath.2018.07.026. Epub 2018 Sep 8.

PMID:
30201497
8.

Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome.

Huang D, Matin SF, Lawrentschuk N, Roupret M.

Bladder Cancer. 2018 Jul 30;4(3):261-268. doi: 10.3233/BLC-180180.

9.

The pulmonary artery-aorta ratio: Is it related to quality of life in chronic obstructive pulmonary disease?

Ghobadi H, Janbazi H, Matin S, Lari SM, Ansarin K.

Clin Respir J. 2018 Aug;12(8):2390-2396. doi: 10.1111/crj.12919.

PMID:
30073796
10.

External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.

Marconi L, de Bruijn R, van Werkhoven E, Beisland C, Fife K, Heidenreich A, Kapoor A, Karam J, Kauffmann C, Klatte T, Ljungberg B, Matin S, Sjoberg D, Staehler M, Stewart GD, Tanguay S, Uzzo R, Welsh S, Wood L, Wood C, Bex A.

World J Urol. 2018 Dec;36(12):1973-1980. doi: 10.1007/s00345-018-2427-z. Epub 2018 Aug 1.

PMID:
30069581
11.

Accuracy of High-Frequency Endoluminal Ultrasonography for Clinical Staging of Upper Tract Urothelial Carcinoma.

Farnum JA, Vikram R, Rao A, Bedi D, Dinney CP, Matin SF.

J Endourol. 2018 Sep 12;32(9):806-811. doi: 10.1089/end.2018.0442. Epub 2018 Aug 21.

PMID:
30014707
12.

Conditional survival of patients with small renal masses undergoing active surveillance.

Petros FG, Venkatesan AM, Kaya D, Ng CS, Fellman BM, Karam JA, Wood CG, Matin SF.

BJU Int. 2019 Mar;123(3):447-455. doi: 10.1111/bju.14486. Epub 2018 Aug 27.

PMID:
30007044
13.

Pilot study of dovitinib in patients with von Hippel-Lindau disease.

Pilié P, Hasanov E, Matin SF, Woodson AHH, Marcott VD, Bird S, Slack RS, Fuller GN, McCutcheon IE, Jonasch E.

Oncotarget. 2018 May 4;9(34):23390-23395. doi: 10.18632/oncotarget.25171. eCollection 2018 May 4.

14.

Salvage topical therapy for upper tract urothelial carcinoma.

Balasubramanian A, Metcalfe MJ, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF.

World J Urol. 2018 Dec;36(12):2027-2034. doi: 10.1007/s00345-018-2349-9. Epub 2018 May 26.

PMID:
29804202
15.

The effect of conjugated linoleic acid on oxidative stress and matrix metalloproteinases 2 and 9 in patients with COPD.

Matin S, Nemati A, Ghobadi H, Alipanah-Moghadam R, Rezagholizadeh L.

Int J Chron Obstruct Pulmon Dis. 2018 May 3;13:1449-1454. doi: 10.2147/COPD.S155985. eCollection 2018.

16.

Misclassification of Upper Tract Urothelial Carcinoma in Patients With Lynch Syndrome.

Matin SF, Coleman JA.

JAMA Oncol. 2018 Jul 1;4(7):1010. doi: 10.1001/jamaoncol.2018.0539. No abstract available.

PMID:
29710233
17.

Endoscopic Approaches to Upper Tract Urothelial Carcinoma.

Petros FG, Li R, Matin SF.

Urol Clin North Am. 2018 May;45(2):267-286. doi: 10.1016/j.ucl.2017.12.009. Epub 2018 Feb 21. Review.

PMID:
29650142
18.

Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.

Shu X, Gu J, Huang M, Tannir NM, Matin SF, Karam JA, Wood CG, Wu X, Ye Y.

Carcinogenesis. 2018 May 28;39(6):752-757. doi: 10.1093/carcin/bgy021.

PMID:
29635281
19.

Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes.

Petros FG, Keskin SK, Yu KJ, Li R, Metcalfe MJ, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CG.

Urology. 2018 Jun;116:114-119. doi: 10.1016/j.urology.2018.03.017. Epub 2018 Mar 22.

PMID:
29578041
20.

The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus.

Hutchinson R, Rew C, Chen G, Woldu S, Krabbe LM, Meissner M, Sheth K, Singla N, Shakir N, Master VA, Karam JA, Matin SF, Borregales LD, Wood C, Masterson T, Thompson RH, Boorjian SA, Leibovich BC, Abel EJ, Bagrodia A, Margulis V.

Urology. 2018 May;115:119-124. doi: 10.1016/j.urology.2018.02.019. Epub 2018 Feb 27.

PMID:
29499258
21.

Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.

Petros FG, Metcalfe MJ, Yu KJ, Keskin SK, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CG.

World J Urol. 2018 Jul;36(7):1093-1101. doi: 10.1007/s00345-018-2241-7. Epub 2018 Feb 27.

PMID:
29488096
22.

Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.

Altok M, Babaian K, Achim MF, Achim GC, Troncoso P, Matin SF, Chapin BF, Davis JW.

BJU Int. 2018 Jul;122(1):66-75. doi: 10.1111/bju.14164. Epub 2018 Mar 25.

PMID:
29446205
23.

The role of surgery in the management of metastatic kidney cancer: an evidence-based collaborative review.

Mir MC, Matin SF, Bex A, Spiess PE, Thompson RH, Grob B, van Poppel H.

Minerva Urol Nefrol. 2018 Apr;70(2):109-125. doi: 10.23736/S0393-2249.18.03055-2. Epub 2018 Jan 29.

24.

Editorial Comment.

Matin SF.

J Urol. 2018 Apr;199(4):938-939. doi: 10.1016/j.juro.2017.10.064. Epub 2018 Jan 10. No abstract available.

PMID:
29331547
25.

Comparison of Placenta PCR and Maternal Serology of Aborted Women for Detection of Toxoplasma gondii in Ardabil, Iran.

Matin S, Shahbazi G, Namin ST, Moradpour R, Feizi F, Piri-Dogahe H.

Korean J Parasitol. 2017 Dec;55(6):607-611. doi: 10.3347/kjp.2017.55.6.607. Epub 2017 Dec 31.

26.

Re: Association Between Lymph Node Yield and Survival Among Patients Undergoing Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Tract.

Petros FG, Matin SF.

Eur Urol. 2018 May;73(5):811-812. doi: 10.1016/j.eururo.2017.12.003. Epub 2017 Dec 14. No abstract available.

PMID:
29249290
27.

Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial.

Bednarski BK, Slack RS, Katz M, You YN, Papadopolous J, Rodriguez-Bigas MA, Skibber JM, Matin SF, Chang GJ.

Dis Colon Rectum. 2018 Jan;61(1):77-83. doi: 10.1097/DCR.0000000000000945.

PMID:
29215474
28.

Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.

Chipollini J, Abel EJ, Peyton CC, Boulware DC, Karam JA, Margulis V, Master VA, Zargar-Shoshtari K, Matin SF, Sexton WJ, Raman JD, Wood CG, Spiess PE.

Clin Genitourin Cancer. 2018 Apr;16(2):e443-e450. doi: 10.1016/j.clgc.2017.10.004. Epub 2017 Oct 17.

PMID:
29113770
29.

Glycemic index, glycemic load and carbohydrate intake in association with risk of renal cell carcinoma.

Zhu J, Tu H, Matin SF, Tannir NM, Wood CG, Wu X.

Carcinogenesis. 2017 Oct 26;38(11):1129-1135. doi: 10.1093/carcin/bgx083.

30.

A decade of robot-assisted radical prostatectomy training: Time-based metrics and qualitative grading for fellows and residents.

Altok M, Achim MF, Matin SF, Pettaway CA, Chapin BF, Davis JW.

Urol Oncol. 2018 Jan;36(1):13.e19-13.e25. doi: 10.1016/j.urolonc.2017.08.028. Epub 2017 Sep 28.

PMID:
28964658
31.

Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.

Wood EL, Adibi M, Qiao W, Brandt J, Zhang M, Tamboli P, Matin SF, Wood CG, Karam JA.

J Urol. 2018 Feb;199(2):393-400. doi: 10.1016/j.juro.2017.09.072. Epub 2017 Sep 20.

PMID:
28941919
32.

Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort.

Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA.

BJU Int. 2018 Apr;121(4):540-548. doi: 10.1111/bju.14021. Epub 2017 Oct 17.

PMID:
28941030
33.

HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.

Sun M, Tong P, Kong W, Dong B, Huang Y, Park IY, Zhou L, Liu XD, Ding Z, Zhang X, Bai S, German P, Powell R, Wang Q, Tong X, Tannir NM, Matin SF, Rathmell WK, Fuller GN, McCutcheon IE, Walker CL, Wang J, Jonasch E.

Cancer Res. 2017 Oct 1;77(19):5313-5326. doi: 10.1158/0008-5472.CAN-17-0986. Epub 2017 Aug 14.

34.

Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.

Metcalfe MJ, Petros FG, Rao P, Mork ME, Xiao L, Broaddus RR, Matin SF.

J Urol. 2018 Jan;199(1):60-65. doi: 10.1016/j.juro.2017.08.002. Epub 2017 Aug 7.

PMID:
28797715
35.

Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.

Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF.

J Endourol. 2017 Sep;31(9):946-953. doi: 10.1089/end.2016.0871. Epub 2017 Jul 21.

36.

Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.

Moss TJ, Qi Y, Xi L, Peng B, Kim TB, Ezzedine NE, Mosqueda ME, Guo CC, Czerniak BA, Ittmann M, Wheeler DA, Lerner SP, Matin SF.

Eur Urol. 2017 Oct;72(4):641-649. doi: 10.1016/j.eururo.2017.05.048. Epub 2017 Jun 7.

PMID:
28601352
37.

Optimizing management of upper tract urothelial carcinoma.

Campbell MT, Shah AY, Matin SF, Siefker-Radtke AO.

Urol Oncol. 2017 Jul;35(7):492-498. doi: 10.1016/j.urolonc.2017.05.009. Epub 2017 Jun 1. Review.

PMID:
28579283
38.

Editorial Comment.

Matin SF.

J Urol. 2017 Sep;198(3):551. doi: 10.1016/j.juro.2017.03.148. Epub 2017 May 24. No abstract available.

PMID:
28551454
39.

Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.

Mendoza-Pérez J, Gu J, Herrera LA, Tannir NM, Zhang S, Matin S, Karam JA, Wood CG, Wu X.

Cancer. 2017 Sep 15;123(18):3617-3627. doi: 10.1002/cncr.30707. Epub 2017 May 23.

40.

Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.

Keskin SK, Msaouel P, Hess KR, Yu KJ, Matin SF, Sircar K, Tamboli P, Jonasch E, Wood CG, Karam JA, Tannir NM.

J Urol. 2017 Sep;198(3):530-537. doi: 10.1016/j.juro.2017.04.067. Epub 2017 Apr 11.

41.

Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.

Abel EJ, Spiess PE, Margulis V, Master VA, Mann M, Zargar-Shoshtari K, Borregales LD, Sexton WJ, Patil D, Matin SF, Wood CG, Karam JA.

J Urol. 2017 Aug;198(2):281-288. doi: 10.1016/j.juro.2017.03.011. Epub 2017 Mar 6.

PMID:
28268170
42.

Interconnection: A qualitative analysis of adjusting to living with renal cell carcinoma.

Leal I, Milbury K, Engebretson J, Matin S, Jonasch E, Tannir N, Wood CG, Cohen L.

Palliat Support Care. 2018 Apr;16(2):146-154. doi: 10.1017/S1478951517000074. Epub 2017 Mar 6.

43.

Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist.

Ferguson JE 3rd, Matin SF.

Eur Urol. 2017 Jun;71(6):987. doi: 10.1016/j.eururo.2017.02.015. Epub 2017 Feb 23. No abstract available.

PMID:
28237787
44.

Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.

Kalra S, Verma J, Atkinson BJ, Matin SF, Wood CG, Karam JA, Lin SH, Satcher RL, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch E.

Clin Genitourin Cancer. 2017 Jun;15(3):363-370. doi: 10.1016/j.clgc.2017.01.010. Epub 2017 Jan 18.

PMID:
28216278
45.

Comparative genomics of two jute species and insight into fibre biogenesis.

Islam MS, Saito JA, Emdad EM, Ahmed B, Islam MM, Halim A, Hossen QM, Hossain MZ, Ahmed R, Hossain MS, Kabir SM, Khan MS, Khan MM, Hasan R, Aktar N, Honi U, Islam R, Rashid MM, Wan X, Hou S, Haque T, Azam MS, Moosa MM, Elias SM, Hasan AM, Mahmood N, Shafiuddin M, Shahid S, Shommu NS, Jahan S, Roy S, Chowdhury A, Akhand AI, Nisho GM, Uddin KS, Rabeya T, Hoque SM, Snigdha AR, Mortoza S, Matin SA, Islam MK, Lashkar MZ, Zaman M, Yuryev A, Uddin MK, Rahman MS, Haque MS, Alam MM, Khan H, Alam M.

Nat Plants. 2017 Jan 30;3:16223. doi: 10.1038/nplants.2016.223.

PMID:
28134914
46.

Robot assisted lymphadenectomy in urology: pelvic, retroperitoneal and inguinal.

Pini G, Matin SF, Suardi N, Desai M, Gill I, Porter J, Stein RJ, Sotelo R, Gaboardi F, Porpiglia F.

Minerva Urol Nefrol. 2017 Feb;69(1):38-55. doi: 10.23736/S0393-2249.16.02823-X. Epub 2016 Nov 8. Review.

PMID:
28009144
47.

Editorial Comment.

Metcalfe MJ, Matin SF.

Urology. 2017 Feb;100:150. doi: 10.1016/j.urology.2016.07.064. Epub 2016 Dec 16. No abstract available.

PMID:
27993389
48.

MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity.

Shu X, Hildebrandt MA, Gu J, Tannir NM, Matin SF, Karam JA, Wood CG, Wu X.

Br J Cancer. 2017 Jan 3;116(1):77-84. doi: 10.1038/bjc.2016.392. Epub 2016 Dec 1.

49.

Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.

Shah AY, Karam JA, Malouf GG, Rao P, Lim ZD, Jonasch E, Xiao L, Gao J, Vaishampayan UN, Heng DY, Plimack ER, Guancial EA, Fung C, Lowas SR, Tamboli P, Sircar K, Matin SF, Kimryn Rathmell W, Wood CG, Tannir NM.

BJU Int. 2017 Dec;120(6):782-792. doi: 10.1111/bju.13705. Epub 2016 Dec 9.

50.

The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients.

Ghobadi H, Matin S, Nemati A, Naghizadeh-Baghi A.

Int J Chron Obstruct Pulmon Dis. 2016 Oct 31;11:2711-2720. eCollection 2016.

Supplemental Content

Support Center